Manulife Financial stock kpis
Annualized Premium Equivalent Sales
Manulife Financial reported annualized premium equivalent sales of C$2.70B in Q2 2026, down 4.4% from Q1 2026 and up 21.0% year over year. The highest value was C$2.82B in Q1 2026.
Calculates the value of new insurance sales, providing insight into growth in the insurance business and future revenue streams.
After years of mid‑cycle volatility, APE sales stepped up materially starting in 2024 and have stayed at a higher run‑rate through 2025 — signaling real sales momentum and likely improved distribution or product traction. That’s bullish for top‑line growth, but quarter‑to‑quarter lumpiness remains pronounced, so watch persistency, margin on new business and acquisition costs: higher APE can boost future revenue but can also pressure near‑term capital and earnings if economics aren’t durable.
MFC Annualized Premium Equivalent Sales
| Period | Annualized Premium Equivalent Sales |
|---|---|
| Q2 2026Jun 30, 2026 | C$2.70B |
| Q1 2026Mar 31, 2026 | C$2.82B |
| Q4 2025Dec 31, 2025 | C$2.22B |
| Q3 2025Sep 30, 2025 | C$2.58B |
| Q2 2025Jun 30, 2025 | C$2.23B |
| Q1 2025Mar 31, 2025 | C$2.69B |
| Q4 2024Dec 31, 2024 | C$2.25B |
| Q3 2024Sep 30, 2024 | C$2.35B |
| Q2 2024Jun 30, 2024 | C$1.91B |
| Q1 2024Mar 31, 2024 | C$1.88B |
| Q4 2023Dec 31, 2023 | C$1.55B |
| Q3 2023Sep 30, 2023 | C$1.66B |
| Q2 2023Jun 30, 2023 | C$1.63B |
| Q1 2023Mar 31, 2023 | C$1.60B |
| Q4 2022Dec 31, 2022 | C$1.29B |
| Q3 2022Sep 30, 2022 | C$1.35B |
| Q2 2022Jun 30, 2022 | C$1.41B |
| Q1 2022Mar 31, 2022 | C$1.61B |
| Q4 2021Dec 31, 2021 | C$1.43B |
| Q3 2021Sep 30, 2021 | C$1.44B |
| Q2 2021Jun 30, 2021 | C$1.42B |
| Q1 2021Mar 31, 2021 | C$1.78B |
| Q4 2020Dec 31, 2020 | C$1.42B |
| Q3 2020Sep 30, 2020 | C$1.43B |
| Q2 2020Jun 30, 2020 | C$1.18B |
| Q1 2020Mar 31, 2020 | C$1.60B |

